Close
Show

Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US

OCTS USA 2022
Trialbee to Power Patient Recruitment for ERGOMED’s New Rare Disease Innovation Center